- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07289633
Evaluación del Dolor Postoperatorio Tras el Uso de Selladores de Resina y Biocerámica en Molares Mandibulares con Periodontitis Apical Asintomática
Evaluación del Efecto de los Selladores de Resina y Biocerámica sobre el Dolor Postoperatorio en Molares Mandibulares con Periodontitis Apical Asintomática Tratados en una Única Visita
The goal of this clinical trial is to compare two root canal sealers in adults who need root canal treatment of a lower back tooth (mandibular first or second molar) with a dead (necrotic) pulp and no pain before treatment. The main question it aims to answer is: Does the type of sealer used to fill the root canals affect pain after single-visit root canal treatment?
Researchers compared a calcium silicate-based sealer (BioRoot RCS) with an epoxy resin-based sealer (AH Plus).
Participants:
Received root canal treatment completed in a single visit, with canals filled using the cold lateral compaction technique and one of the two sealers, assigned at random Recorded their pain on a 100 mm visual analog scale at 6, 12, and 24 hours and on days 2, 3, 5, and 7 after treatment Recorded whether, when, and how much pain medication (ibuprofen) they took during the 7-day follow-up
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
This single-center, parallel-group randomized controlled trial was conducted at the Department of Endodontics, Faculty of Dentistry, Atatürk University (Erzurum, Türkiye). Seventy patients with a mandibular first or second molar with pulp necrosis and either normal apical tissues or asymptomatic apical periodontitis (periapical index score ≤ 3), without preoperative pain, were randomly allocated in a 1:1 ratio to the BioRoot RCS group or the AH Plus group (35 per group).
All treatments were performed in a single visit by one operator following a standardized protocol. Canals were shaped with the WaveOne Gold reciprocating system and irrigated with 2.5% sodium hypochlorite, followed by final irrigation with 17% EDTA, 2.5% sodium hypochlorite, and saline. Allocation was concealed in sequentially numbered, opaque, sealed envelopes opened immediately before obturation. In both groups, canals were obturated by cold lateral compaction, and the teeth were permanently restored in the same visit.
The primary outcome was postoperative pain intensity on a 100 mm visual analog scale at 6, 12, and 24 hours and on days 2, 3, 5, and 7. The secondary outcome was the proportion of participants who used rescue analgesics (ibuprofen 400 mg) during the 7-day follow-up.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
palandöken
-
Erzurum, palandöken, Turquía (Türkiye), 25100
- Atatürk University Faculty of Dentistry
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Age 18-65 years
- American Society of Anesthesiologists (ASA) physical status I
- Mandibular first or second molar with complete root formation and no previous endodontic treatment
- Pulp necrosis (no response to cold and electric pulp tests), confirmed clinically by the absence of bleeding in the pulp chamber during access cavity preparation
- Normal apical tissues or asymptomatic apical periodontitis according to the American Association of Endodontists diagnostic terminology (periapical index score of 3 or less)
- No spontaneous pain and no tenderness to percussion or palpation before treatment
- No analgesic intake within the previous 72 hours and no antibiotic intake within the previous month
- Written informed consent
Exclusion Criteria:
- Systemic disease, immunodeficiency, or regular medication use
- Pregnancy
- Known allergy to the materials or drugs used in the study
- Symptomatic apical periodontitis, acute apical abscess, or chronic apical abscess
- Swelling or sinus tract
- Periodontal probing depth greater than 3 mm
- Root canal calcification, internal or external root resorption, or open apex
- Teeth requiring a post-and-core restoration
- Periapical index score greater than 3
- Bleeding in the pulp chamber during access cavity preparation (pulp necrosis not confirmed)
- Two canals in the distal root
- Treatment that could not be completed in a single visit or that required intracanal medication
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Doble
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: BioRoot RCS Group
Single-visit root canal treatment of mandibular molars with pulp necrosis; canals obturated by cold lateral compaction using the calcium silicate-based sealer BioRoot RCS. |
Single-visit root canal treatment of mandibular first or second molars with pulp necrosis and either normal apical tissues or asymptomatic apical periodontitis (PAI ≤ 3). Canals were shaped with the WaveOne Gold reciprocating system, irrigated with 2.5% NaOCl, and finally irrigated with 17% EDTA, 2.5% NaOCl, and saline. Canals were obturated by cold lateral compaction using gutta-percha cones and the calcium silicate-based sealer BioRoot RCS (Septodont). No intracanal medication was used. |
|
Comparador activo: AH Plus Group
Single-visit root canal treatment of mandibular molars with pulp necrosis; canals obturated by cold lateral compaction using the epoxy resin-based sealer AH Plus. |
Single-visit root canal treatment of mandibular first or second molars with pulp necrosis and either normal apical tissues or asymptomatic apical periodontitis (PAI ≤ 3). Canals were shaped with the WaveOne Gold reciprocating system, irrigated with 2.5% NaOCl, and finally irrigated with 17% EDTA, 2.5% NaOCl, and saline. Canals were obturated by cold lateral compaction using gutta-percha cones and the epoxy resin-based sealer AH Plus (Dentsply DeTrey). No intracanal medication was used. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Postoperative pain intensity
Periodo de tiempo: 6, 12, and 24 hours and 2, 3, 5, and 7 days after treatment
|
Postoperative pain intensity was self-recorded by participants on a 100 mm visual analog scale (VAS), where 0 mm indicates no pain and 100 mm indicates the worst imaginable pain. VAS scores were categorized as no pain (0-4 mm), mild (5-34 mm), moderate (35-64 mm), severe (65-85 mm), and very severe pain (86-100 mm), and the groups were compared at each time point. |
6, 12, and 24 hours and 2, 3, 5, and 7 days after treatment
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Proportion of participants using analgesics
Periodo de tiempo: From the end of treatment to day 7 after treatment
|
Proportion of participants in each group who took rescue analgesic medication (ibuprofen 400 mg, taken only in case of severe pain) during the follow-up period, as self-recorded on the pain record form together with the time and dose of each intake. |
From the end of treatment to day 7 after treatment
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- B.30.2ATA.0.01.00/559
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .